Recipient aging accelerates acquired transthyretin amyloidosis after domino liver transplantation

Liver Transplantation - Tập 22 Số 5 - Trang 656-664 - 2016
Yohei Misumi1, Yuki Narita2, Toshinori Oshima1, Mitsuharu Ueda1, Taro Yamashita1, Masayoshi Tasaki3,4, Konen Obayashi3, Kaori Isono2, Yukihiro Inomata2, Yukio Ando1
1Departments of Neurology,Kumamoto University,Kumamoto,Japan
2Departments of Transplantation and Pediatric Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan
3Departments of Morphological and Physiological Sciences, Graduate School of Health Sciences,Kumamoto University,Kumamoto,Japan
4Departments of Morphological and Physiological Sciences, Graduate School of Health SciencesKumamoto UniversityKumamotoJapan

Tóm tắt

Domino liver transplantation (DLT) with liver grafts from patients with hereditary transthyretin (TTR) amyloidosis has been performed throughout the world because of a severe liver graft shortage. Reports of acquired systemic TTR amyloidosis in domino liver recipients have been increasing; however, the precise pathogenesis and clinical course of acquired TTR amyloidosis remains unclear. We analyzed the relationship between the occurrence of acquired amyloidosis and clinical features in 22 consecutive domino liver donors with hereditary TTR amyloidosis (10 males and 12 females; mean age at DLT: 37.2 years; TTR mutations: V30M [n = 19], Y114C [n = 1], L55P [n = 1], and S50I [n = 1]) and 22 liver recipients (16 males and 6 females; mean age at DLT, 46.2 years). The mean times from DLT to amyloid first appearance and transplant recipient symptom onset were 8.2 years and 9.9 years, respectively. Kaplan‐Meier analysis and quantification of the amyloid deposition revealed aging of recipients correlated with early de novo amyloid deposition. The sex of donors and recipients and the age, disease duration, and disease severity of donors had no significant effect on the latency of de novo amyloid deposition. In conclusion, our results demonstrate that recipient aging is associated with the early onset de novo amyloidosis. Because acquired amyloidosis will likely increase, careful follow‐up for early amyloidosis detection and new treatments, including TTR stabilizers and gene‐silencing therapies, are required. Liver Transplantation 22 656‐664 2016 AASLD.

Từ khóa


Tài liệu tham khảo

2005, Transthyretin‐related familial amyloidotic polyneuropathy, Arch Neurol, 62, 1057, 10.1001/archneur.62.7.1057

2005, The biological and chemical basis for tissue‐selective amyloid disease, Cell, 121, 73, 10.1016/j.cell.2005.01.018

2013, Guideline of transthyretin‐related hereditary amyloidosis for clinicians, Orphanet J Rare Dis, 8, 31, 10.1186/1750-1172-8-31

1993, Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis, Lancet, 341, 1113, 10.1016/0140-6736(93)93127-M

2012, Long‐term survival after liver transplantation in patients with familial amyloid polyneuropathy, Neurology, 78, 637, 10.1212/WNL.0b013e318248df18

2011, Manifestations of transthyretin‐related familial amyloidotic polyneuropathy: long‐term follow‐up of Japanese patients after liver transplantation, Surg Today, 41, 1211, 10.1007/s00595-010-4488-5

2011, Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients, Amyloid, 18, 200, 10.3109/13506129.2011.615872

2010, Liver transplantation and combined liver‐heart transplantation in patients with familial amyloid polyneuropathy: a single‐center experience, Liver Transpl, 16, 314, 10.1002/lt.21996

1998, Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy, Transplantation, 65, 1496, 10.1097/00007890-199806150-00016

2004, Deposition and passage of transthyretin through the blood‐nerve barrier in recipients of familial amyloid polyneuropathy livers, Lab Invest, 84, 865, 10.1038/labinvest.3700107

2005, Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation, N Engl J Med, 352, 2356, 10.1056/NEJM200506023522219

2006, Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation, Am J Transplant, 6, 2512, 10.1111/j.1600-6143.2006.01484.x

2007, Transthyretin‐derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver, Liver Transpl, 13, 215, 10.1002/lt.20954

2008, Domino liver transplantation: risks and benefits, Transplant Proc, 40, 1130, 10.1016/j.transproceed.2008.03.020

2010, Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation, Liver Transpl, 16, 1386, 10.1002/lt.22174

2010, Acquired amyloid neuropathy in a Portuguese patient after domino liver transplantation, Muscle Nerve, 42, 836, 10.1002/mus.21806

2011, Amyloid neuropathy in a younger domino liver transplanted recipient, Muscle Nerve, 43, 449, 10.1002/mus.21941

2011, Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation, J Neurol Neurosurg Psychiatry, 82, 1287, 10.1136/jnnp.2010.218958

2012, Amyloid polyneuropathy following domino liver transplantation, Muscle Nerve, 45, 918, 10.1002/mus.23265

2013, Evaluation of domino liver transplantations in Germany, Transpl Int, 26, 715, 10.1111/tri.12110

2014, Domino liver transplantation as a cause of acquired familial amyloid polyneuropathy, Amyloid, 21, 136, 10.3109/13506129.2014.885894

1999, Outcome of liver transplantation for transthyretin amyloidosis: follow‐up of Japanese familial amyloidotic polyneuropathy patients, J Neurol Sci, 171, 19, 10.1016/S0022-510X(99)00231-2

2014, Age‐specific population frequencies of cerebral β‐amyloidosis and neurodegeneration among people with normal cognitive function aged 50‐89 years: a cross‐sectional study, Lancet Neurol, 13, 997, 10.1016/S1474-4422(14)70194-2

2006, Amyloid contained in the knee joint meniscus is formed from apolipoprotein A‐I, Arthritis Rheum, 54, 3545, 10.1002/art.22201

2012, The occurrence of islet amyloid polypeptide amyloidosis in Japanese subjects, Pancreas, 41, 971, 10.1097/MPA.0b013e318249926a

2011, Ageing: A risk factor for amyloid A amyloidosis in rheumatoid arthritis, Amyloid, 18, 108, 10.3109/13506129.2011.582198

2008, Electrophysiological features of late‐onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci, J Neurol, 255, 1526, 10.1007/s00415-008-0962-z

2014, Efficacy of diflunisal on autonomic dysfunction of late‐onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area, J Neurol Sci, 345, 231, 10.1016/j.jns.2014.07.017

2011, Wild‐type transthyretin‐derived amyloidosis in various ligaments and tendons, Hum Pathol, 42, 1259, 10.1016/j.humpath.2010.11.017

2015, Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis, Mod Pathol, 28, 201, 10.1038/modpathol.2014.102

2008, Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity, Amyloid, 15, 255, 10.1080/13506120802525285

2004, Transthyretin aggregation under partially denaturing conditions is a downhill polymerization, Biochemistry, 43, 7365, 10.1021/bi049621l

2012, Clinical and biomarker changes in dominantly inherited Alzheimer's disease, N Engl J Med, 367, 795, 10.1056/NEJMoa1202753